摘要
Type 2 diabetes （T2D） is the most common cause of chronic kidney disease （CKD） and end-stage renal disease worldwide. In China, approximately 21.3% of diabetes was estimated to accompany with CKD and the number of diabetes-related CKDs was 24.3 million, of whom 60.5% preserved renal dysfunction with slightly increased albuminuria. In the light of the prevalence and massive health and financial toll,
Type 2 diabetes （T2D） is the most common cause of chronic kidney disease （CKD） and end-stage renal disease worldwide. In China, approximately 21.3% of diabetes was estimated to accompany with CKD and the number of diabetes-related CKDs was 24.3 million, of whom 60.5% preserved renal dysfunction with slightly increased albuminuria. In the light of the prevalence and massive health and financial toll,
